Edwards Lifesciences Corp

EW 10-Q · Q1 2026

EW Q1 2026 request

Playground key active
Request URL /api/financials?ticker=EW&year=2026&quarter=1
waiting 0 ms
Pick an endpoint and run the request.
curl

Income Statement

Income Statement
Metric Q1 2026 Q1 2025 YoY
Revenue (Q) — — —
Show Product Lines breakouts
Surgical 276.2 250.9 +10.1%
Transcatheter Aortic Valve Replacement 1,197.3 1,046.6 +14.4%
Transcatheter Mitral and Tricuspid Therapies 175.1 115.2 +52.0%
Show Business Segments breakouts
Europe · Operating Segments 442.6 341.8 +29.5%
Japan · Operating Segments 90.6 81.8 +10.8%
Rest of World · Operating Segments 177.8 150.2 +18.4%
United States · Operating Segments 937.6 838.9 +11.8%
Show — breakouts
Revenue 1,648.6 1,412.7 +16.7%
Show Consolidation Items breakouts
Operating Segments 1,648.6 1,412.7 +16.7%
Cost of Revenue (Q) — — —
Show Business Segments breakouts
Europe · Operating Segments 93.6 82.2 +13.9%
Japan · Operating Segments 14.3 12.3 +16.3%
Rest of World · Operating Segments 47.6 39.8 +19.6%
United States · Operating Segments 172 146 +17.8%
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income 2.5 -10.2 +124.5%
Show — breakouts
Cost of Revenue 362.6 301.6 +20.2%
Show Consolidation Items breakouts
Operating Segments 327.5 280.3 +16.8%
Gross Profit (Q) — — —
Show — breakouts
Gross Profit 1,286 1,111.1 +15.7%
Selling, General & Administrative (Q) — — —
Show Business Segments breakouts
Europe · Operating Segments 71.8 73.4 -2.2%
Japan · Operating Segments 15.9 16.4 -3.0%
Rest of World · Operating Segments 48 42.1 +14.0%
United States · Operating Segments 154.1 133.2 +15.7%
Show — breakouts
Selling, General & Administrative 522.2 465.7 +12.1%
Show Consolidation Items breakouts
Operating Segments 289.8 265.1 +9.3%
Research & Development (Q) — — —
Show — breakouts
Research & Development 263.3 254.6 +3.4%
Litigation Settlement Expense (Q) — — —
Show — breakouts
Litigation Settlement Expense 37.1 10.9 +240.4%
Show Consolidation Items breakouts
Material Reconciling Items 37.1 10.9 +240.4%
Other Operating Income Expense Net (Q) — — —
Show — breakouts
Other Operating Income Expense Net -14.2 -19.1 +25.7%
Operating Income (Q) — — —
Show — breakouts
Operating Income 477.6 394.8 +21.0%
Show Consolidation Items breakouts
Operating Segments 1,002.1 888.8 +12.7%
Interest Income (Q) — — —
Show — breakouts
Interest Income -33.5 -36.5 +8.2%
Variable Interest Entity Loss On Impairment (Q) — — —
Show — breakouts
Variable Interest Entity Loss On Impairment 123.6 — —
Show Consolidated Entities breakouts
Variable Interest Entity Not Primary Beneficiary · Medical Device Company February 2019 Investment 123.6 — —
Other Non-Operating Income (Expense) (Q) — — —
Show Equity Components breakouts
Accumulated Translation Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income -1.6 -1.7 +5.9%
Show — breakouts
Other Non-Operating Income (Expense) -71.5 -2.6 -2650.0%
Income Before Taxes (Q) — — —
Show — breakouts
Income Before Taxes 459 433.9 +5.8%
Income Tax Expense (Benefit) (Q) — — —
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income -0.8 2.7 -129.6%
Accumulated Net Unrealized Investment Gain Loss · Reclassification Out Of Accumulated Other Comprehensive Income 3.9 4.2 -7.1%
Accumulated Translation Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income 0.4 0.4 0.0%
Show — breakouts
Income Tax Expense (Benefit) 78.3 70.3 +11.4%
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest (Q) — — —
Show — breakouts
Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest 380.7 363.6 +4.7%
Net Income (Q) — — —
Show Equity Components breakouts
Accumulated Gain Loss Net Cash Flow Hedge Parent · Reclassification Out Of Accumulated Other Comprehensive Income -1.7 7.5 -122.7%
Accumulated Net Unrealized Investment Gain Loss · Reclassification Out Of Accumulated Other Comprehensive Income 12.2 12.8 -4.7%
Accumulated Translation Adjustment · Reclassification Out Of Accumulated Other Comprehensive Income 1.2 1.3 -7.7%
Retained Earnings 380.7 358 +6.3%
Show — breakouts
Net Income 380.7 356.4 +6.8%
Net Income (Q) — — —
Show — breakouts
Net Income 380.7 358 +6.3%
Income Loss From Continuing Operations Per Basic Share (Q) — — —
Show — breakouts
Income Loss From Continuing Operations Per Basic Share 0.66 0.62 +6.5%
EPS (Basic) (Q) — — —
Show — breakouts
EPS (Basic) 0.66 0.61 +8.2%
Income Loss From Continuing Operations Per Diluted Share (Q) — — —
Show — breakouts
Income Loss From Continuing Operations Per Diluted Share 0.66 0.62 +6.5%
EPS (Diluted) (Q) — — —
Show — breakouts
EPS (Diluted) 0.66 0.61 +8.2%
Wtd Avg Shares (Basic) (Q) — — —
Show — breakouts
Wtd Avg Shares (Basic) 579.2 586.9 -1.3%
Wtd Avg Shares (Diluted) (Q) — — —
Show — breakouts
Wtd Avg Shares (Diluted) 580.7 587.8 -1.2%
Total Costs & Expenses (Q) — — —
Show Consolidation Items breakouts
Corporate Non Segment -494.8 -486.2 -1.8%
Non-Operating Income (Expense) (Q) — — —
Show — breakouts
Non-Operating Income (Expense) -18.6 39.1 -147.6%
Comprehensive Income (Q) — — —
Show — breakouts
Comprehensive Income 397.7 348 +14.3%
Other Comprehensive Income (Q) — — —
Show Equity Components breakouts
Accumulated Other Comprehensive Income 17 -10 +270.0%
Show — breakouts
Other Comprehensive Income 17 -10 +270.0%
Interest Income Expense Net (Q) — — —
Show — breakouts
Interest Income Expense Net 33.5 36.5 -8.2%
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments (Q) — — —
Show Business Segments breakouts
Europe · Operating Segments 235.3 194.5 +21.0%
Japan · Operating Segments 66.4 57.7 +15.1%
Rest of World · Operating Segments 89.7 77.5 +15.7%
United States · Operating Segments 610.7 559.1 +9.2%
Show Consolidation Items breakouts
Operating Segments 1,002.1 888.8 +12.7%
Foreign Currency Transaction Gain Loss Before Tax (Q) — — —
Show Consolidation Items breakouts
Material Reconciling Items 7.4 7.3 +1.4%

Balance Sheet

Balance Sheet
Metric Q1 2026 Q1 2025 YoY
Current Assets
Cash & Cash Equivalents (Q) — — —
Show — breakouts
Cash & Cash Equivalents 2,445.5 — —
Short-Term Investments (Q) — — —
Show — breakouts
Short-Term Investments 1,226 — —
Accounts Receivable (Q) — — —
Show — breakouts
Accounts Receivable 775.7 — —
Other Receivables Net Current (Q) — — —
Show — breakouts
Other Receivables Net Current 197.3 — —
Inventory (Q) — — —
Show — breakouts
Inventory 1,119 — —
Prepaid Expense Current (Q) — — —
Show — breakouts
Prepaid Expense Current 135.7 — —
Other Assets Current (Q) — — —
Show — breakouts
Other Assets Current 329.5 — —
Total Current Assets (Q) — — —
Show — breakouts
Total Current Assets 6,228.7 — —
Non-Current Assets
Long Term Investments (Q) — — —
Show — breakouts
Long Term Investments 285.6 — —
Property, Plant & Equipment (Q) — — —
Show — breakouts
Property, Plant & Equipment 1,823.1 — —
Operating Lease Right-of-Use Assets (Q) — — —
Show — breakouts
Operating Lease Right-of-Use Assets 99.3 — —
Goodwill (Q) — — —
Show — breakouts
Goodwill 1,819.6 — —
Deferred Tax Assets (Q) — — —
Show — breakouts
Deferred Tax Assets 1,098.1 — —
Other Non-Current Assets (Q) — — —
Show — breakouts
Other Non-Current Assets 738.9 — —
Total Assets (Q) — — —
Show — breakouts
Total Assets 13,321.2 — —
Other Assets
Intangible Assets Net Excluding Goodwill (Q) — — —
Show — breakouts
Intangible Assets Net Excluding Goodwill 1,227.9 — —
Current Liabilities
Accounts Payable (Q) — — —
Show — breakouts
Accounts Payable 181.1 — —
Accrued And Other Liabilities Current (Q) — — —
Show — breakouts
Accrued And Other Liabilities Current 1,203.6 — —
Operating Lease Liability Current (Q) — — —
Show — breakouts
Operating Lease Liability Current 24.3 — —
Total Current Liabilities (Q) — — —
Show — breakouts
Total Current Liabilities 1,409 — —
Non-Current Liabilities
Long-Term Debt (Q) — — —
Show — breakouts
Long-Term Debt 598.5 — —
Operating Lease Liabilities (Q) — — —
Show — breakouts
Operating Lease Liabilities 80.1 — —
Liability For Uncertain Tax Positions Noncurrent (Q) — — —
Show — breakouts
Liability For Uncertain Tax Positions Noncurrent 555.4 — —
Other Non-Current Liabilities (Q) — — —
Show — breakouts
Other Non-Current Liabilities 350.7 — —
Total Liabilities (Q) — — —
Show — breakouts
Total Liabilities 2,993.7 — —
Stockholders' Equity
Common Stock (Q) — — —
Show — breakouts
Common Stock 660 — —
Additional Paid In Capital Common Stock (Q) — — —
Show — breakouts
Additional Paid In Capital Common Stock 2,781.5 — —
Retained Earnings (Q) — — —
Show — breakouts
Retained Earnings 14,621.2 — —
Accumulated Other Comprehensive Income (Q) — — —
Show — breakouts
Accumulated Other Comprehensive Income -221.3 — —
Treasury Stock Common Value (Q) — — —
Show — breakouts
Treasury Stock Common Value -7,513.9 — —
Total Stockholders' Equity (Q) — — —
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment 1 — —
Accumulated Gain Loss Net Cash Flow Hedge Parent 8.4 — —
Accumulated Net Unrealized Investment Gain Loss -1.2 — —
Accumulated Other Comprehensive Income -221.3 — —
Accumulated Translation Adjustment -229.5 — —
Additional Paid In Capital 2,781.5 — —
Common Stock 660 — —
Retained Earnings 14,621.2 — —
Treasury Stock Common -7,513.9 — —
Show — breakouts
Total Stockholders' Equity 10,327.5 — —
Total Liabilities & Equity (Q) — — —
Show — breakouts
Total Liabilities & Equity 13,321.2 — —

Cash Flow Statement

Cash Flow Statement
Metric YTD Q1 2026 YTD Q1 2025 YoY
Operating Activities
Depreciation & Amortization (Q) — — —
Show — breakouts
Depreciation & Amortization 40.9 36.6 +11.7%
Operating Lease Right Of Use Asset Amortization Expense (Q) — — —
Show — breakouts
Operating Lease Right Of Use Asset Amortization Expense 6.5 6.1 +6.6%
Stock-Based Compensation (Q) — — —
Show — breakouts
Stock-Based Compensation 45.4 40.2 +12.9%
Gain Loss On Investments (Q) — — —
Show — breakouts
Gain Loss On Investments 3.5 12.5 -72.0%
Increase Decrease In Deferred Income Taxes (Q) — — —
Show — breakouts
Increase Decrease In Deferred Income Taxes 9.4 -24.3 +138.7%
Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss (Q) — — —
Show — breakouts
Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss -65.2 — —
Asset Impairment Charges (Q) — — —
Show — breakouts
Asset Impairment Charges 123.6 — —
Other Non-Cash Items (Q) — — —
Show — breakouts
Other Non-Cash Items 0.5 3.6 -86.1%
Increase Decrease In Accounts And Other Receivables (Q) — — —
Show — breakouts
Increase Decrease In Accounts And Other Receivables -117.9 -43.7 -169.8%
Change in Inventory (Q) — — —
Show — breakouts
Change in Inventory -1.6 -0.1 -1500.0%
Increase Decrease In Accounts Payable And Accrued Liabilities (Q) — — —
Show — breakouts
Increase Decrease In Accounts Payable And Accrued Liabilities -347.1 -103.4 -235.7%
Increase Decrease In Accrued Income Taxes Payable (Q) — — —
Show — breakouts
Increase Decrease In Accrued Income Taxes Payable 41.9 51.2 -18.2%
Change in Prepaid & Other Assets (Q) — — —
Show — breakouts
Change in Prepaid & Other Assets -8.7 10.6 -182.1%
Increase Decrease In Legal Settlement Accrual (Q) — — —
Show — breakouts
Increase Decrease In Legal Settlement Accrual -50 -36.7 -36.2%
Increase Decrease In Other Operating Capital Net (Q) — — —
Show — breakouts
Increase Decrease In Other Operating Capital Net -18.1 -28.6 +36.7%
Net Cash from Operations (Q) — — —
Show — breakouts
Net Cash from Operations 43.8 280.4 -84.4%
Investing Activities
Capital Expenditures (Q) — — —
Show — breakouts
Capital Expenditures -64.9 -56 -15.9%
Payments To Acquire Interest In Subsidiaries And Affiliates (Q) — — —
Show — breakouts
Payments To Acquire Interest In Subsidiaries And Affiliates -6.3 — —
Payments To Acquire Held To Maturity Securities (Q) — — —
Show — breakouts
Payments To Acquire Held To Maturity Securities -12.5 -12.8 +2.3%
Proceeds From Sale And Maturity Of Held To Maturity Securities (Q) — — —
Show — breakouts
Proceeds From Sale And Maturity Of Held To Maturity Securities 12.5 17.7 -29.4%
Purchases of Investments (Q) — — —
Show — breakouts
Purchases of Investments -641.1 -634.5 -1.0%
Proceeds From Sale And Maturity Of Available For Sale Securities (Q) — — —
Show — breakouts
Proceeds From Sale And Maturity Of Available For Sale Securities 710.1 827.9 -14.2%
Payments To Acquire Businesses Net Of Cash Acquired Excluding Options (Q) — — —
Show — breakouts
Payments To Acquire Businesses Net Of Cash Acquired Excluding Options -35.1 — —
Payments To Acquire Receivables (Q) — — —
Show — breakouts
Payments To Acquire Receivables -55.2 -17.8 -210.1%
Other Investing Activities (Q) — — —
Show — breakouts
Other Investing Activities -0.3 0.1 -400.0%
Net Cash from Investing (Q) — — —
Show — breakouts
Net Cash from Investing -92.8 85.3 -208.8%
Financing Activities
Share Repurchases (Q) — — —
Show — breakouts
Share Repurchases -421.8 -258.6 -63.1%
Payments For Equity Forward Contract Related To Accelerated Share Repurchase Agreement (Q) — — —
Show — breakouts
Payments For Equity Forward Contract Related To Accelerated Share Repurchase Agreement -100 -50 -100.0%
Proceeds From Stock Plans (Q) — — —
Show — breakouts
Proceeds From Stock Plans 68.9 49.9 +38.1%
Proceeds From Payments For Other Financing Activities (Q) — — —
Show — breakouts
Proceeds From Payments For Other Financing Activities 1.7 0.7 +142.9%
Net Cash from Financing (Q) — — —
Show — breakouts
Net Cash from Financing -451.2 -258 -74.9%
Supplemental
Unpaid Capital Expenditures (Q) — — —
Show — breakouts
Unpaid Capital Expenditures 39.9 31.2 +27.9%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents (Q) — — —
Show — breakouts
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 8.2 -17.7 +146.3%
Net Change in Cash (Q) — — —
Show — breakouts
Net Change in Cash -492 90 -646.7%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents (Q) — — —
Show — breakouts
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 2,447.5 3,148.8 -22.3%

Values in millions USD. Source: SEC EDGAR 10-Q filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key